Fat's loss is bone's gain

Journal of Clinical Investigation

Volumn 113, Issue 6, 2004, Pages 805-806

  Pei, Liming ^a   Tontonoz, Peter ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALENDRONIC ACID; CALCIUM; FAT; PARATHYROID HORMONE[1-34]; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RISEDRONIC ACID; VITAMIN D;

AGED; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; FRACTURE; GLUCOSE HOMEOSTASIS; HEALTH HAZARD; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; LIPOGENESIS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 2142808834     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21311     Document Type: Review

References (15)

1. Karsenty, G., and Wagner, E.F. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:389-406.
2. Boyle, W.J., Simonet, W.S., and Lacey, D.L. 2003. Osteoclast differentiation and activation. Nature. 423:337-342.
3. Harada, S., and Rodan, G.A. 2003. Control of osteoblast function and regulation of bone mass. Nature. 423:349-355.
4. Rosen, E.D., and Spiegelman, B.M. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16:145-171.
5. Hu, E., Tontonoz, P., and Spiegelman, B.M. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. U. S. A. 92:9856-9860.
6. Skillington, J., Choy, L., and Derynck, R. 2002. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J. Cell Biol. 159:135-146.
7. Jeon, M.J., et al. 2003. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J. Biol. Chem. 278:23270-23277.
8. Lecka-Czernik, B., et al. 2002. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology. 143:2376-2384.
9. Meunier, P., Aaron, J., Edouard, C., and Vignon, G. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. 80:147-154.
10. Akune, T., et al. 2004. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113:846-855. doi:10.1172/JCI200419900.
11. Prestwood, K.M., Pilbeam, C.C., and Raisz, L.G. 1995. Treatment of osteoporosis. Annu. Rev. Med. 46:249-256.
12. Berg, C., Neumeyer, K., and Kirkpatrick, P. 2003. Teriparatide. Nat. Rev. Drug Discov. 2:257-258.
13. Klein, R.F., et al. 2004. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science. 303:229-232.
14. Huang, J.T., et al. 1999. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 400:378-382.
15. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A., and Evans, R.M. 1998. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:241-252.